相关期刊:《World Journal of Experimental Medicine》《Oncology and Translational Medicine》《Journal of Clinical & Translational Research》《Journal of Zhejiang University-Science B(Biomedicine & Biotechnology)》更多>>
the Key R&D Program of the Science and Technology Ministry of China(No.2021YFC2701100);the National Natural Science Foundation of China(No.82150008,81930036);the Commission of Science and Technology of Shanghai Municipality,China(No.20JC1418500).
Glioblastoma multiforme(GBM)is the most malignant intracranial tumor in adults and its unique pathology leads to limited therapeutic benefits.1,2 Mitochondrial fusion and fission play an important role in carcinogenes...
Glioblastoma multiforme(GBM)is a common brain tumor that rarely metastasizes extra-cranially.We present the case of a 40-year-old male with left temporal GBM who underwent craniotomy followed by radiotherapy and chemo...
Human cytomegalovirus (HCMV) was reported in glioblastoma multiforme (GBM) over a decade ago and this finding has the potential to increase our understanding of the disease and it offers an alternative tumor-specific ...
Supported by M.P.Biotech Council,M.P.for financial assistance and BMHRC for infrastructural facilities,No.249
Glioblastoma-multiforme(GBM), the most aggressive glial tumor, has a worldwide age-adjusted incidence ranging from 0.59-3.69/100000 persons. Despite current multimodal-treatment approach, median-survival time and prog...
High?grade gliomas of the spinal cord represent a rare entity in children.Their biology,behavior,and controversial treatment options have been discussed in a few pediatric cases.These tumors are associated with severe...
Gliosarcoma is rare central nervous system tumour and a variant of glioblastoma multiforme with bimorphic histological pattern of glial and sarcomatous differentiation. It occurs in elderly between 5^(th) and 6^(th) d...
Background:Glioblastoma(GBM)is the most frequent and most malignant central nervous system(CNS)tumor.GBM shows poor prognosis with a median overall survival of 14.6 months,despite current surgical and adjuvant therapi...
Supported by the National Natural Science Foundation of China(31000559)
Glioblastoma multiforme(GBM)is the most malignant brain tumor with high infiltration.The routine surgical resection followed by radiation and chemotherapy only provides patients with a survival period ranging 12–15mo...
Delayed cerebral ischemia (DCI) due to post-brain tumor resection vasospasm is an often unrecognized yet debilitating complication. We present a patient with DCI after the resection of glioblastoma multiforme (GBM). T...
Purpose: Radiotherapy with concurrent temozolomide (TMZ), followed by 6 cycles of adjuvant TMZ, is the standard of care for newly diagnosed Glioblastoma Mulltiforme (GBM). However tumor progression is the role with me...